SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-023920
Filing Date
2020-02-21
Accepted
2020-02-21 16:40:26
Documents
3
Period of Report
2020-02-13
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207951d1_8k.htm 8-K 18920
2 EXHIBIT 99.1 tm207951d1_ex99-1.htm EX-99.1 23103
3 GRAPHIC image_001.jpg GRAPHIC 3071
  Complete submission text file 0001104659-20-023920.txt   47651
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 000-55535 | Film No.: 20640652
SIC: 2834 Pharmaceutical Preparations